Skip to main content
Screener/Healthcare/Biotechnology

CTXR — Citius Pharmaceuticals, Inc.

NASDAQ
$0.40-0.02 (-5.01%)
$0.39
$1.98
$0.39
$0.41
EPS (TTM)$-2.57
P/E Ratio-0.39
Dividend Yield—
Market Cap$7.7M
Volume377K
Prev Close$0.42
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q2 '26$1.7M-$28.1M$-0.95-22.9%-1685.9%
Q1 '26$3.9M-$8.2M$-0.3865.5%-208.4%
Q4 '25$0-$8.0M$-0.44——
Q3 '25$0-$8.8M$-0.80——
Q2 '25$0-$10.9M$-1.27——
Q1 '25$0-$9.8M$-1.30——
Q4 '24$156K-$10.8M$-1.70-34.4%-6920.1%
Q3 '24$0-$10.6M$-1.57——
Get Your Daily Market Recap